The survivin/GAPDH ratio of carcinomas (mean±standard error (s.e.): 5.3±0.8, range: 0.4–37) was significantly higher than that of non-cancerous tissues (3.6±0.8, range: 0–37.5, P=0.0003). This evidence concerns the gene GAPDH and carcinoma.